Large Platform (MAMS) Trials Necessary for Parkinson’s, Review Argues

Large Platform (MAMS) Trials Necessary for Parkinson’s, Review Argues
A clinical trial that’s multi-arm and multi-stage (MAMS) could quicken development of promising therapies for Parkinson’s disease (PD) by allowing multiple treatments to be tested simultaneously. MAMS trials, most commonly used across cancers, may be a way of advancing work toward a first therapy that can delay or stop Parkinson’s progression, the researchers wrote, adding their goal is to “make ... read more
Source: Parkinson’s News TodayPublished on 2020-05-11By Marisa Wexler